(Q113942531)
Statements
A Single/Multiple Ascending Dose Phase 1 Study Of The Safety, Tolerability, And Pharmacokinetics Of Intranasal 2-Deoxy-D-Glucose In Normal Healthy Volunteers (English)
0 references
3 March 2022
0 references
August 2022
0 references
45
0 references
18 year
0 references
99 year
0 references